Micafungin Labatec 50 mg, poudre pour solution à diluer pour perfusion - Swissmedic Key 69511001 Registration Holder Labatec Pharma SA Name Micafungin Labatec 50 mg, poudre pour solution à diluer pour perfusion Date of registration 18.06.2024 Introduction of Sequence 18.06.2024 ATC-Classification Micafungin (J02AX05) Revision date WHO WHO-DDD Valid until 17.06.2029 Index Therapeuticus (BSV) Show package size Index Therapeuticus (Swissmedic) 08.06. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680695110012 Medication Code Synthetika Pharmacode Disponibility
Composition Praeparatio cryodesiccata: micafunginum 50 mg ut micafunginum natricum 50.86 mg, lactosum monohydricum, acidum citricum, natrii hydroxidum, pro vitro corresp. natrium 0.92 mg. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form poudre pour solution à diluer pour perfusion Excipiens Active Agent Dose Micafunginum 50 mg
Inactive agents Citric Acid Lactose Monohydrate Sodium Hydroxide
Source Data was imported : 04.07.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
